Retinal Tumors

This refers to tumors or cancers that form in the retina, the light-sensitive tissue at the back of the eye. These can be benign (not cancerous) or malignant (cancerous).

Condition

What people with Retinal Tumors report

Every report comes from a Lived member, sent anonymously.

Have you had Eye Enucleation for Retinal Tumors?

NameHow it went

About Retinal Tumors

What It Is

Retinal tumors are abnormal growths in the retina, the thin layer of light-sensitive tissue lining the back of the eye that turns light into signals the brain reads as vision. Because the retina is so central to sight, even a small tumor can blur or block vision, and some retinal tumors are cancers that can spread beyond the eye. The term covers several different conditions. The most important is retinoblastoma, a cancer of the retina that develops in young children, most often before age 2. It is the most common eye cancer in children and is often curable when found early. Other retinal tumors include hemangioblastomas, usually noncancerous growths made of blood vessels that occur in an inherited condition called von Hippel-Lindau (VHL) disease, and vitreoretinal lymphoma, a rare cancer of immune cells that affects the retina and the clear gel inside the eye (the vitreous). Melanoma inside the eye usually starts in the layer beneath the retina rather than in the retina itself, and is a separate topic.

Causes & Risk Factors

Retinoblastoma is caused by changes in a gene called RB1, which normally acts as a brake on cell growth. When both copies of the gene stop working in a developing retinal cell, that cell can divide out of control. In about a third of children the RB1 change is heritable: it is present in every cell of the body, either passed from a parent or arising around conception. These children usually develop tumors in both eyes, can pass the change to their own children, and have a higher risk of other cancers later in life. In the other two thirds, the changes happen by chance in the eye alone, usually affect one eye and are not passed on. Without genetic testing it can be hard to tell the two forms apart in a child with a tumor in one eye, which is why genetic testing and counseling are part of care for the whole family. Retinal hemangioblastomas are the most frequent eye feature of VHL disease, affecting roughly half of people with the condition, and they can appear in childhood or adulthood. Retinal tumors also occur in tuberous sclerosis complex, another inherited condition. Vitreoretinal lymphoma is considered part of the same family as lymphoma that starts in the brain. For many retinal tumors, the underlying condition matters as much as the eye itself.

How It's Diagnosed

Most retinal tumors are found by an eye specialist looking directly at the retina after widening the pupil with drops. In young children this examination is often done under anesthesia so the whole retina can be checked carefully, along with the other eye. Ultrasound of the eye and magnetic resonance imaging (MRI) scans show the tumor's size and whether it has spread, and retinoblastoma can usually be diagnosed from these findings without taking a tissue sample (biopsy). A blood test for RB1 changes helps show whether the heritable form is present, which affects follow-up for the child and testing for brothers, sisters and parents. For retinal hemangioblastomas, photographs of the retina and a dye test (fluorescein angiography, in which a dye injected into the arm lights up the retinal blood vessels) help find small tumors. Anyone found to have one should be offered genetic testing for VHL disease, since the condition can affect the brain, kidneys and other organs. Vitreoretinal lymphoma is harder to recognize because it often looks like long-lasting eye inflammation (uveitis) that does not respond as expected to treatment. Confirming it requires a biopsy of the vitreous gel, analyzed with laboratory tests for lymphoma cells and markers, and an evaluation of the brain and spinal fluid.

Treatment Options

Treatment depends on the type of tumor, its size and location, and whether one or both eyes are affected. Care is usually led by specialized centers, because these tumors are rare and the choices are technical. For retinoblastoma, the goals in order are to save the child's life, then to save the eye and as much vision as possible, while limiting long-term side effects. Small tumors can be destroyed with laser heat or freezing (cryotherapy). Larger tumors are often shrunk first with chemotherapy, given through a vein, delivered directly into the artery that supplies the eye, or injected into the eye when tumor seeds have spread into the vitreous. Radiation, including a small radioactive disc stitched to the outside of the eye for a few days (plaque radiotherapy), is used in selected cases, though external radiation raises the later risk of second cancers in children with the heritable form. When a tumor is large, does not respond or comes back and vision cannot be saved, the eye is removed (enucleation) and the child is later fitted with an artificial eye. Cancer that has spread beyond the eye needs intensive chemotherapy, sometimes with high-dose treatment and a stem cell transplant. Retinal hemangioblastomas are usually treated early with laser or freezing while they are small, because growing tumors can leak fluid, bleed or detach the retina. Tumors next to the optic nerve are harder to treat without harming vision. Belzutifan (Welireg), a daily pill approved for some VHL tumors in the kidney, brain, spinal cord and pancreas, has shrunk retinal tumors in studies, but it is not specifically approved for them, and it can harm a developing fetus, so pregnancy must be ruled out and effective nonhormonal contraception used. Vitreoretinal lymphoma is treated with chemotherapy injected into the eye (methotrexate, sometimes with rituximab, an antibody against lymphoma cells), radiation to the eyes, or chemotherapy through a vein when the brain is involved or at high risk. There is no single standard approach.

What to Expect

The outlook depends heavily on the type of tumor. In the United States, most retinoblastomas are found while still confined to the eye, and more than 95 out of 100 children are alive five years after diagnosis. Survival is lower when the cancer has spread outside the eye, and much lower if it reaches the brain or spinal fluid, which is why early diagnosis matters so much. Treatment is followed by frequent eye exams, often under anesthesia in young children, because new tumors can appear for a few years in the heritable form. Survivors of heritable retinoblastoma carry a lifelong higher risk of other cancers, such as bone and soft tissue cancers and melanoma, so long-term survivorship care with a plan for future screening is part of life after treatment. Hearing, learning and the growth of the bone around a removed eye are also followed. For people with VHL disease, eye care is lifelong: guidelines recommend screening from the first year of life, every 6 to 12 months until age 30 and at least yearly after that, along with checks of other organs. Vitreoretinal lymphoma often responds well at first, but it frequently returns and can spread to the brain, so ongoing follow-up with both an eye specialist and a cancer specialist is needed.

When to Seek Help

Have a child seen by a doctor soon if one pupil looks white instead of red in light or in flash photos, if the eyes seem to point in different directions, or if an eye looks red, cloudy or larger than the other. These signs often have other causes, but retinoblastoma is most treatable when found early. Children with a family history of retinoblastoma should have regular eye exams from early in life unless genetic testing shows they did not inherit the RB1 change, and people with VHL disease should keep to their screening schedule even when their vision seems fine. At any age, seek medical care right away for new flashes of light, a sudden increase in floaters or a sudden change in vision, since these can signal bleeding or detachment of the retina. If you are being treated for a retinal tumor, contact your care team about any new change in vision or eye pain.

Questions to Ask Your Doctor

  1. 1.What type of retinal tumor is this, and is it a cancer or a noncancerous growth?
  2. 2.Is this tumor linked to an inherited condition, and should we have genetic testing and counseling for our family?
  3. 3.What are the realistic chances of saving the eye and useful vision with each treatment option?
  4. 4.How often will eye exams and scans be needed, and for how long?
  5. 5.What long-term effects of treatment should we watch for, and who will coordinate that follow-up care?

Last reviewed • Oct 2026

Educational content, not medical advice.